Daniela Bellomo

TTfactor SRL develops oncology research, technology advancement and intellectual property transfer programs. It operates as a technology transfer and market connection company focused on the advancement of scientific results through technology licensing, sponsored research, clinical trials, drug discovery, and molecular medicine programs. The company was founded by Daniela Bellomo in 2010 and is headquartered in Milan, Italy.

IMBcom Pty Ltd. provides skills and support to the researchers in commercializing the results of their discoveries. It also provides Intellectual property development, Commercial development, Corporate Alliances, Government liaison, Preparation of business plans and commercially focused grants, Capital raising and negotiation for venture capital Market analysis and Technology licensing. The firm manages the IMB's intellectual property as developers and drivers, resulting in licenses, contracts and the formation of start-up companies. The company was founded in 2000 and is headquartered in Brisbane, Australia.

Fondazione San Raffaele del Monte Tabor-Milano provides medical care and clinical support to patients. They carry out biomedical research and clinical activities. The company is based in Milan, Italy.

Parco Tecnologico Padano Srl engages in science park operations. The firm manages the PTP Science Park in the province of Lodi which hosts experimental research and development facilities in the agricultural sector. Its facility includes universities, institutions, and public and private research laboratories. The company was founded in 2000 and is headquartered in Lodi, Italy.

GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy.

Biovelocita Srl (Biovelocita) is a venture capital firm founded in 2015 by Silvano Spinelli, Gabriella Camboni and Sofinnova Partners. The firm is headquartered in Milan, Italy.

Repron Therapeutics Srl is an Italian company that operates as an epigenetic silencing platform for tumor recurrence repression. The company is based in Milan, Italy. The company was founded by Alessandro Sessa and Vania Broccoli.